NO20100811L - Subenhetsvaksine for akvakutur - Google Patents

Subenhetsvaksine for akvakutur

Info

Publication number
NO20100811L
NO20100811L NO20100811A NO20100811A NO20100811L NO 20100811 L NO20100811 L NO 20100811L NO 20100811 A NO20100811 A NO 20100811A NO 20100811 A NO20100811 A NO 20100811A NO 20100811 L NO20100811 L NO 20100811L
Authority
NO
Norway
Prior art keywords
subunit vaccine
aquaculture
antigenic
amino acid
acid sequence
Prior art date
Application number
NO20100811A
Other languages
English (en)
Other versions
NO20100811A (no
Inventor
Tsun-Yung Kuo
Hsuchung Gabriel Chen
Chungchin Wu
Mercy Inderjit Singh
Oystein Evensen
Original Assignee
Schweitzer Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweitzer Co Ltd filed Critical Schweitzer Co Ltd
Publication of NO20100811A publication Critical patent/NO20100811A/no
Publication of NO20100811L publication Critical patent/NO20100811L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/00034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Animal Husbandry (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det beskrives en akvatisk subenhetsvaksine omfattende et antigenisk fusjonsprotein og en egnet barer eller adj uvant. Fra aminoterminus til karboksylterminus består den antigeniske fusjonsproteinsekvens av en reseptorbindingsdel og et translokasjonsdomene av Pseudomonas aeruginosa eksotoksin A og har aminosyresekvensen SEQ ID NR.: 8; et viralt, antigenisk protein som påvirker fiskesykdom; og et sig na I peptid med aminosyresekvensen SEQ ID NR.: 10.
NO20100811A 2007-12-04 2010-06-04 Subenhetsvaksine for akvakutur NO20100811L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2007/003438 WO2009070929A1 (en) 2007-12-04 2007-12-04 A subunit vaccine for aquaculture

Publications (2)

Publication Number Publication Date
NO20100811A NO20100811A (no) 2010-08-27
NO20100811L true NO20100811L (no) 2010-08-27

Family

ID=40717262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20100811A NO20100811L (no) 2007-12-04 2010-06-04 Subenhetsvaksine for akvakutur

Country Status (7)

Country Link
US (1) US8343505B2 (no)
JP (1) JP5132780B2 (no)
CN (1) CN101883580B (no)
CA (1) CA2707919C (no)
GB (1) GB2467722B (no)
NO (1) NO20100811L (no)
WO (1) WO2009070929A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009070929A1 (en) 2007-12-04 2009-06-11 Schweitzer Co., Ltd. A subunit vaccine for aquaculture
UA113192C2 (xx) 2011-12-06 2016-12-26 Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
GB201309664D0 (en) * 2013-05-30 2013-07-17 Univ Aberdeen Fish vaccine
CN110438090B (zh) * 2013-05-31 2023-12-05 英特维特国际股份有限公司 鳞片脱落疾病(sdd)致病病毒及其衍生物
KR102041032B1 (ko) * 2015-06-01 2019-11-27 레버 제네틱스 컴퍼니 리미티드 돼지 생식기 호흡기 증후군 및 돼지 써코바이러스 연관 질환에 대한 백신 조성물
US20210368745A1 (en) * 2017-12-21 2021-12-02 Gis Gas Infusion Systems Inc. Method and apparatus for fish farms
CN116510001B (zh) * 2023-06-26 2023-11-24 西北农林科技大学深圳研究院 一种水产养殖用mRNA疫苗及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1059599C (zh) * 1996-12-27 2000-12-20 中国科学院水生生物研究所 蛙病毒疫苗
EP1075523B1 (en) * 1998-05-08 2007-08-08 Intervet International BV Structural proteins of fish pancreatic disease virus and uses thereof
JP3681933B2 (ja) * 1999-09-29 2005-08-10 三郎 原 ビルナウイルスサブユニットワクチン
CN1311036A (zh) * 2000-02-29 2001-09-05 中国科学院南海海洋研究所 一种抗海水养殖动物弧菌病的混合疫苗及其制备方法
US7807144B2 (en) * 2001-09-05 2010-10-05 Academia Sinica Oral vaccines
WO2003101482A2 (en) * 2002-05-31 2003-12-11 Genesis Group Inc. Liposome vaccine formulations for fin-fish
US20040024761A1 (en) * 2002-07-13 2004-02-05 Kolbe Steven J. Web-besed, industry specific, staffing interactive database
JP4578973B2 (ja) * 2002-09-17 2010-11-10 ノバルティス アーゲー 免疫刺激のためのｉｈｎｖｇ蛋白質
TWI350310B (en) * 2002-12-13 2011-10-11 Novartis Ag Immunization of fish with plant-expressed recombinant proteins
US7335361B2 (en) * 2003-06-09 2008-02-26 Animal Technology Institute Taiwan Fusion antigen used as vaccine
US20070243587A1 (en) * 2006-04-14 2007-10-18 Healthbanks Biotech Co., Ltd. Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus
WO2009070929A1 (en) 2007-12-04 2009-06-11 Schweitzer Co., Ltd. A subunit vaccine for aquaculture

Also Published As

Publication number Publication date
GB201010584D0 (en) 2010-08-11
JP2011505391A (ja) 2011-02-24
JP5132780B2 (ja) 2013-01-30
US8343505B2 (en) 2013-01-01
CA2707919A1 (en) 2009-06-11
CA2707919C (en) 2014-02-11
US20100316663A1 (en) 2010-12-16
WO2009070929A1 (en) 2009-06-11
CN101883580A (zh) 2010-11-10
GB2467722B (en) 2012-03-07
NO20100811A (no) 2010-08-27
CN101883580B (zh) 2013-12-25
GB2467722A (en) 2010-08-11

Similar Documents

Publication Publication Date Title
NO20100811L (no) Subenhetsvaksine for akvakutur
ES2558330T3 (es) Péptido WT1 restringido por HLA-A*3303 y composición farmacéutica que comprende el mismo
ES2589057T3 (es) Proteína quimérica
ES3058501T3 (en) Rsv f protein mutants
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
RU2011151877A (ru) Пептиды, проникающие в клетку
PE20140986A1 (es) Proteinas de fusion y vacunas de combinacion que comprenden proteina e y pilina a de haemophilus influenzae
RU2015122371A (ru) Слитые белки для применения в качестве иммуногенных усиливающих агентов для индуцирования антигенспецифического т-клеточного ответа
ES2571879T3 (es) Moléculas de una sola cadena de TNFSF
NO20063026L (no) Antistoffer
CL2013003634A1 (es) Complejo que comprende una proteina de fusion que comprende, un peptido viral, peptido conector, microglobulina beta 2 , peptido conector, dominios extracelulares alfa 1, 2 y 3 de mhc de clase i y un tercer peptido conector; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso
JP2016196472A5 (no)
HRP20191614T1 (hr) Spojevi koji su suagonisti gip i glp-1
PE20240015A1 (es) Proteinas de fusion gdf15 y usos de estas
PE20130615A1 (es) Polipeptidos del receptor de activina variante y uso de los mismos
PE20212075A1 (es) PROTEINAS DE FUSION Fc IL-22 Y METODOS DE USO
UA103154C2 (uk) Hla-a*1101-обмежений пептид wt1 і фармацевтична композиція, яка містить його
EP1992639A4 (en) PEPTIDE VACCINE FOR INDUCING THE PRODUCTION OF AN ANTIAMYLOID PEPTIDANT BODY
KR20000005429A (ko) 비수지성 주쇄 펩티드 담체
IL195338A (en) An antibody comprising an FC variant containing amino acid replaces d or e at position 239, a medicament containing it and its use
EA201000077A1 (ru) Вирус гриппа с нарушенной репликацией для экспрессии гетерологичных последовательностей
HRP20150664T1 (hr) Antikancerogeni fuzijski protein
AR079114A1 (es) Proteinas de enlace de antigenos anti-orai1 y usos de las mismas
JP2017522319A5 (no)
JP2016516734A5 (no)

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SBC VIRBAC LIMITED, HK

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: VIRBAC HK TRADING LIMITED, HK